Edition:
United Kingdom

Adaptimmune Therapeutics Reports Quarterly Loss Per Ordinary Share Of $0.05


Thursday, 15 Mar 2018 

March 15 (Reuters) - Adaptimmune Therapeutics Plc ::ADAPTIMMUNE REPORTS FOURTH QUARTER / FULL YEAR 2017 FINANCIAL RESULTS AND BUSINESS UPDATE.ADAPTIMMUNE THERAPEUTICS PLC QUARTERLY LOSS PER ORDINARY SHARE $0.05.ADAPTIMMUNE THERAPEUTICS - BELIEVES EXISTING CASH AND CASH EQUIVALENTS, SHORT-TERM DEPOSITS TO FUND CURRENT OPERATING PLAN THROUGH TO EARLY 2020.ADAPTIMMUNE THERAPEUTICS PLC QUARTERLY REVENUE $4.3 MILLION VERSUS $8.5 MILLION. 

Company Quote

3.38
-0.11 -3.15%
7:39pm BST